GT Medical Technologies Names Dr. Michael A. Garcia as Chief Medical Officer

TEMPE, Ariz., March 16, 2023—GT Medical Technologies, Inc. has appointed Michael A. Garcia, MD, MS, as its Chief Medical Officer. 

In his new role, Dr. Garcia will expand the GammaTile® Therapy clinical study pipeline, support research and development, lead medical affairs, and promote additional efforts for expanding the evidence-based use of GammaTile Therapy and its incorporation into oncology care guidelines. Continue reading

ReSuture, Inc. Awarded $996,413 NSF Phase II Small Business Innovation Research Grant to Support Surgical Performance and Medical Device Development

  • $996,413 Phase II SBIR grant from the NSF advances ReSuture’s efforts to quantify operative performance through simulated surgical platforms, capacitive sensing, and machine learning

  • ReSuture’s proposed technology – a combination of lifelike physical simulations, novel sensors, and robust data analysis – is addressing a universal market need that has been unsolved for decades

  • ReSuture’s early working solutions have been adopted by device manufacturers W.L. Gore, Teleflex Medical, Becton Dickinson, Endologix, and surgical residency programs at Tulane Medical Center, McMaster University, and the Mayo Clinic

Continue reading